The Importance of AMH For IVF Success

If you’ve ever gone down the IVF rabbit  hole, you’ve probably heard this phrase more times than you can count:

“What’s your AMH?” It’s treated like the number, the one that predicts your chances, your outcome, your hope. Often, we rely on the importance of AMH for IVF success, but the 2026 guidelines from the European Society of Human Reproduction and Embryology (ESHRE) just gave us a much needed reality check!

What Is AMH (and Why Do We Care So Much)?

Anti-Müllerian Hormone (AMH) is a blood test used to estimate your ovarian reserve, essentially, how many eggs you may have left. Clinics use it to predict how your ovaries might respond to stimulation and help decide medication doses, as well as plan your IVF protocol. Often, women rely on their AMH for IVF success, believing that the higher their AMH number is, the more likely they are to be able to get pregnant. Hence, AMH is considered important. It is, but here is the key update…

AMH should NOT be used to predict chances of pregnancy or live birth. Yes, you read that right. AMH can predict how your ovaries respond to stimulation and help estimate egg yield. However, what AMH cannot do is predict if you’ll get pregnant or if you’ll have a live birth.

So, What Actually Predicts IVF Success, you ask? According to the guidelines, two factors matter more, age and BMI. These have a stronger association with pregnancy and live birth outcomes than ovarian reserve markers like AMH. This means you can have a “low AMH” and still get pregnant, and you can have a “high AMH” and still struggle. AMH is about quantity, and not quality, and in IVF, egg quality (largely influenced by age) is often the real game-changer.

What Next?

IVF is more nuanced than one number. It is multi-factorial. It depends on age, egg quality, sperm quality, uterine environment, lab conditions, and protocol choices, not just on one hormone level. ESHRE still supports using AMH, just appropriately. To tailor medication doses, identify low or high responders, and reduce risks like Ovarian Hyperstimulation syndrome (OHSS)

In conclusion,

AMH is a tool, not a verdict. It helps doctors plan your treatment, not predict your future. And maybe, that’s the shift we needed, from fear-based interpretation to an informed and balanced understanding.

Let’s Talk! Have you had your AMH tested and did it match your expectations, or surprise you?